leadf
logo-loader
viewAdvantage Lithium Corp.

Advantage Lithium adds second rig to Cauchari drilling to expand resource

The work is focused on expanding the existing resource and testing a large exploration target.

1-shutterstock_199537001.jpg
Cauchari is in Argentina..

Advantage Lithium Corp (CVE:AAL; OTCQX:AVLIF) revealed it has added a second rig to speed up drilling at the excitingh Cauchari Salar lithium property of Jujuy province in Argentina.

The work at the property is focused on expanding the existing resource and testing a large exploration target.

As revealed previously, the property has a resource of 11.75 mt (million tons) of Lithium Carbonate Equivalent (LCE) at an average grade of 585 mg/l (miligrams per litre).

The Cauchari asset lies just 20 km south of Orocobre's flagship Olaroz lithium facility, while the firm  is also earning an interest from Nevada Sunrise Gold Corp, in a portfolio of five lithium brine projects in the Clayton and Lida Valley regions of Nevada, USA, including 70% in Clayton NE.

David Sidoo, the chief executive of Advantage Lithium, told investors today: "The second drill rig will fast track the development program on our Cauchari project.

"Our exploration team, headed by Miguel Peral, is doing an excellent job of advancing this drill program."

He said the work was designed to test the exploration target at significantly greater depths than previous drilling.

"This very exciting project is in the heart of the lithium triangle, between established lithium producer Orocobre and the Cauchari development project of Lithium Americas-SQM and represents one of the best undeveloped lithium brine opportunities in South America. At this time lithium assay results are expected to be available in late August," he added.

Quick facts: Advantage Lithium Corp.

Price: 0.265 CAD

TSX-V:AAL
Market: TSX-V
Market Cap: $43.14 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Orthocell 'in exciting regulatory phase' as it looks to drive its...

Orthocell Ltd's (ASX:OCC) Paul Anderson says the company's in an exciting regulatory phase having validated its technologies in the clinic and defining pathways to market through the US FDA process. ''We have some significant milestones ahead of us - we have an application within the FDA at the...

17 hours, 57 minutes ago

2 min read